Effective supply chain surveillance for PPE thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
If the first number that pops into your head when you think about body temperature is 98.6°F, you have a study from 1851 to thank for that. Carl Reinhold August Wunderlich, a German doctor, took multiple axillary (armpit) temperatures from about 25,000 people, and based on an analysis, he established 98.6°F (or 37°Celsius) as the norm.
The reality though is that normal body temperature is on a spectrum, not an absolute. Body temperature can depend on your age, the time of day, and what you were doing before you popped the thermometer in your mouth or zapped your forehead.
If you’re wondering whether your numbers are normal (and what to do if they’re not), or even if you’re using the thermometer the right way, consider this your crash course on everything body temperature-related.
Published Wed May 05 2021 15:57:54 GMT+0000 (Coordinated Universal Time) by Lynn Arditi
Rhode Island physicians groups are sounding alarms about legislation moving through the General Assembly that they say would strip the authority of the state health director over emergency medical services.
The legislation (H-6282 and S-860) would prevent the health director from enacting EMS regulations, protocols and licensing requirements without the approval of a 25-member board that currently serves in an advisory capacity. The single-largest constituency of the Ambulance Service Coordinating Advisory Board are municipal fire departments, which run almost all of the state’s EMS agencies.
The Rhode Island State Association of Fire Fighters and the Rhode Island League of Cities and Towns are supporting the legislation. The Rhode Island Medical Society, the American College of Cardiology, the American Heart Association, Rhode Island Chapter of the American College of Em
Share this article
WASHINGTON, May 4, 2021 /PRNewswire/ A new case report, detailed in
Annals of Emergency Medicine, is the first known case of a patient with VITT (vaccine-induced thrombotic thrombocytopenia) treated with a heparin alternative following the Centers for Disease Control and Prevention (CDC) guidance.
An otherwise healthy female patient in her 40s came to the emergency department at UCHealth University of Colorado Hospital twelve days after receiving the Johnson & Johnson vaccine with a headache, dizziness, and vision changes. The patient was treated on April 13, 2021, the same day that the Centers for Disease Control and Prevention (CDC) announced a pause in the administration of the Johnson & Johnson vaccine. CDC guidance recommended treatment with heparin alternatives but did not recommended any specific alternative in that announcement.